Skip to Content

Publications Search - Abstract View

Title: TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Authors: Killela PJ,  Reitman ZJ,  Jiao Y,  Bettegowda C,  Agrawal N,  Diaz LA Jr,  Friedman AH,  Friedman H,  Gallia GL,  Giovanella BC,  Grollman AP,  He TC,  He Y,  Hruban RH,  Jallo GI,  Mandahl N,  Meeker AK,  Mertens F,  Netto GJ,  Rasheed BA,  Riggins GJ,  Rosenquist TA,  Schiffman M,  Shih IeM,  Theodorescu D,  Torbenson MS,  Velculescu VE,  Wang TL,  Wentzensen N,  Wood LD,  Zhang M,  McLendon RE,  Bigner DD,  Kinzler KW,  Vogelstein B,  Papadopoulos N,  Yan H
Journal: Proc Natl Acad Sci U S A
Date: 2013 Apr 9
Branches: CGB, HREB
PubMed ID: 23530248
PMC ID: PMC3625331
Abstract: Malignant cells, like all actively growing cells, must maintain their telomeres, but genetic mechanisms responsible for telomere maintenance in tumors have only recently been discovered. In particular, mutations of the telomere binding proteins alpha thalassemia/mental retardation syndrome X-linked (ATRX) or death-domain associated protein (DAXX) have been shown to underlie a telomere maintenance mechanism not involving telomerase (alternative lengthening of telomeres), and point mutations in the promoter of the telomerase reverse transcriptase (TERT) gene increase telomerase expression and have been shown to occur in melanomas and a small number of other tumors. To further define the tumor types in which this latter mechanism plays a role, we surveyed 1,230 tumors of 60 different types. We found that tumors could be divided into types with low (<15%) and high (≥15%) frequencies of TERT promoter mutations. The nine TERT-high tumor types almost always originated in tissues with relatively low rates of self renewal, including melanomas, liposarcomas, hepatocellular carcinomas, urothelial carcinomas, squamous cell carcinomas of the tongue, medulloblastomas, and subtypes of gliomas (including 83% of primary glioblastoma, the most common brain tumor type). TERT and ATRX mutations were mutually exclusive, suggesting that these two genetic mechanisms confer equivalent selective growth advantages. In addition to their implications for understanding the relationship between telomeres and tumorigenesis, TERT mutations provide a biomarker that may be useful for the early detection of urinary tract and liver tumors and aid in the classification and prognostication of brain tumors.